|
Volumn 316, Issue 2, 2016, Pages 143-144
|
An HIV vaccine mapping uncharted territory
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BROADLY NEUTRALIZING ANTIBODY;
EPITOPE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOGLOBULIN G ANTIBODY;
NEUTRALIZING ANTIBODY;
POXVIRUS VECTOR;
RECOMBINANT HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEIN;
RECOMBINANT PROTEIN;
RECOMBINANT VIRUS ENVELOPE PROTEIN;
UNCLASSIFIED DRUG;
VIRUS ENVELOPE PROTEIN;
RECOMBINANT VACCINE;
ANTIBODY PRODUCTION;
B LYMPHOCYTE;
CELL CLONING;
CELL LINEAGE;
CRYOELECTRON MICROSCOPY;
CYTOLYSIS;
DRUG BINDING;
DRUG DESIGN;
HIGH THROUGHPUT SEQUENCING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE EVASION;
IMMUNE RESPONSE;
INFECTION PREVENTION;
LYMPHOCYTE ACTIVATION;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROTEIN CONFORMATION;
VIRAL CLEARANCE;
VIRUS GENE;
VIRUS MUTATION;
VIRUS NEUTRALIZATION;
X RAY CRYSTALLOGRAPHY;
HIV INFECTIONS;
IMMUNOLOGY;
AIDS VACCINES;
ANTIBODY FORMATION;
HIV INFECTIONS;
HUMANS;
VACCINES, SYNTHETIC;
VIRAL ENVELOPE PROTEINS;
|
EID: 84978438185
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2016.7538 Document Type: Note |
Times cited : (24)
|
References (7)
|